NAFLD is a liver disease with metabolic disorders related to obesity and diabetes, miR-21 can also regulate triglyceride and cholesterol metabolism in NAFLD by targeting HMGCR [59]. Here, HMGCR is linked to metabolic dysfunction-associated steatotic liver disease.